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Abstract Purpose: In the present study, we investigated the presence of human papillomavirus (HPV) DNA0196-0709/$ – see fro
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E-mail address: lpand viral types in 75 cases of oral squamous cells carcinoma from Brazil to obtain data that would
contribute to a better understanding of the role of HPV in the pathogenesis of this tumor.
Materials and methods: DNA was extracted from paraffin-embedded tissue and amplified by
polymerase chain reaction using a pair of primers designated PCO3+ and PCO4+ for the detection of
a fragment of the human h-globin gene, followed by polymerase chain reaction for the detection of
HPV DNA using a pair of generic primers, GP5+ and GP6+. Viral typing was performed by dot blot
hybridization.
Results: Human papillomavirus DNA was detected in 18 (24%) of the 75 cases positive for the
human h-globin gene. No significant association was observed between HPV and age, sex, or
anatomical location of the tumor. The most prevalent viral type was HPV-18 (77,8%).
Conclusion: The low frequency of detection of HPV DNA in oral epidermoid carcinomas suggests a
possible participation of the virus in the development and progression of only a subgroup of these
tumors.D 2007 Published by Elsevier Inc.1. Introduction
Oral cancer is a severe and growing public health
problem in Brazil. Its etiology is complex; and many
factors, mainly smoking and alcohol, have been associated
with this type of cancer [1]. In addition, biological agents
such as viruses represent important factors able to induce
neoplastic alterations. Among these agents, human papillo-
mavirus (HPV) seems to play an important role in the
induction of oral cancer.
The association between oncogenic HPVs and cancer
has been well established for anogenital and uterine cervicalnt matter D 2007 Published by Elsevier Inc.
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pinto@digi.com.br (L.P. Pinto).carcinomas, but their relationship with oral squamous cells
carcinoma (OSCC) is uncertain. Over the past years,
various studies have investigated the role of HPVs in
OSCC; but the results are highly controversial. So far, more
than 130 different viral genotypes infecting the skin and
mucosa have been described [2]. Most studies have
indicated HPV-16 as the most prevalent HPV type in both
oral and genital tumors [3].
In view of the importance of this virus in carcinogenesis,
we investigated the presence of HPV DNA and the most
frequent types in patients with OSCC.2. Subjects and methods
Samples from 75 patients were collected from archived
paraffin-embedded OSSC specimens from the Dr Luis
Antoˆnio Hospital Department of Pathology between 2000d Neck Medicine and Surgery 28 (2007) 397–400
Fig. 1. Detection of h-globin gene DNA. Lanes 1 to 7, samples from
patients; lane 8, C33 cell DNA without HPV infection; lane 9, negative
control; lane 10, molecular marker (100 bp).
Table 1
Comparison of sex and anatomical location between HPV-positive and
HPV-negative cases (Natal/RN, 2005)
Clinical characteristics Total HPV positive HPV negative P4
n n % n %
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were men and 26 (34.7%) were women. Patient age ranged
from 30 to 93 years, with a mean of 65.45 years. In the
present study, all carcinomas were primary tumors located
in the oral cavity, with 20 tumors involving the tongue,
17 the floor of the mouth, 14 the lower lip, 8 the jugal
mucosa, 6 the palate, 5 the alveolar border, and 5 the
retromolar trigone.
Ten 10-Am-thick histologic sections were obtained for
DNA extraction, and two 3-Am sections were stained with
hematoxylin/eosin for review by a pathologist.
DNA was extracted using the ammonium acetate-
isopropanol technique, which does not require the use of
phenol-chloroform. This method was developed by the
research team of the Laboratory of Molecular Biology,
Dental School of the University of Sa˜o Paulo, and consisted
of the initial removal of paraffin by baths in xylene heated to
658C. Next, the tissues were hydrated in a decreasing
ethanol series (absolute, 95%, 70%, and 50%). Afterward,
400-AL sterile lysis buffer (50 mmol/L NaCl, 5 mmol/L
Tris-HCl, pH 8, 12.5 mmol/L EDTA, pH 8, and 0.25%
sodium dodecyl sulfate) and proteinase K at a final
concentration of 500 Ag/mL were added to the tissue pellet
of each sample; and the samples were incubated at 558C for
3 to 5 days until complete dissolution of the material.
Proteinase K (250 Ag/mL) was added at 24-hour intervals.
After this step, proteinase K was inactivated by incubation
of the material at 958C for 10 minutes. Next, 200 AL of a
4-mol/L ammonium acetate solution was added to each
sample for protein precipitation, followed by 600 AL 100%
isopropanol for DNA precipitation. Finally, the DNA pellets
obtained were washed with 70% ethanol, dissolved in 50 AL
Tris-EDTA buffer, and stored at 208C.
To evaluate the efficacy of DNA extraction, all samples
were submitted to polymerase chain reaction (PCR) for
amplification of the human h-globin gene that is present inFig. 2. Detection of HPV DNA in samples from patients with OSCC. Lanes
1 to 7, samples from patients; lane 8, HeLa cell DNA infected with
HPV-18; lane 9, negative control; lane 10, molecular marker (100 bp).all human cells. For this, a pair of primers designated
PCO3+ (5VCTTCTGACACAACTGTGTTCACTAGC3V)
and PCO4+ (5VTCACCGCAAC TTCATCCACGT-
TCACC3V) was used, which amplifies a fragment of about
110 base pairs (bp) of the h-globin gene [4].
Polymerase chain reactionwas carried out in an Eppendorf
thermocycler in a reaction mixture containing the following
components in a final volume of 50 AL: 0.5 Amol/L of the
PCO3 and PCO4 primers (Invitrogen, Life Technologies,
Carlsbad, CA), 1.0 U Taq DNA polymerase (Biosystem,
Campinas, Brazil), 20 mmol/L Tris-HCl, pH 8.4, 50 mmol/L
KCl, 1.5 mmol/L MgCl2, 200 Amol/L dNTP (Amersham
Bioscience, Buckinghamshire, England), and 0.7 or 7 AL
sample DNA. The PCR conditions for amplification of the
h-globin gene were as follows: initial denaturation at 958C
for 4 minutes; followed by 40 cycles of amplification at 958C
for 1 minute, 508C for 1 minute, and 728C for 1 minute; and a
final extension step at 728C for 10 minutes. The PCR
products were analyzed by electrophoresis on 2.5% agarose
gel (Nusieve) stained with ethidium bromide.
The samples positive for h-globin were analyzed by PCR
regarding the presence of HPV DNA using pair of generic
primers, GP5+ (5VTTTGTTACTGTGGTAGATACTAC3V)
and GP6+ (5VGAAAAATA AACTGTAAATCAT ATTC3V)
[5], which flanks a fragment of about 140 bp of the L1 gene,
a highly conserved sequence in the genome of mucosal
(genital and oral) HPVs. The use of this primer pair permits
the detection and amplification of this DNA segment from
at least 23 individual mucosal (genital and oral) HPV types,
including high-risk HPV types.
The reaction mixture contained 1.0 Amol/L GP5+/GP6+
(Invitrogen, Life Technologies), 1.0 U Taq DNA polymer-
ase (Biosystem), 20 mmol/L Tris-HCl, pH 8.4, 50 mmol/L
KCl, 1.5 mmol/L MgCl2, 200 Amol/L deoxyribonucleotide
triphosphate (Amersham Bioscience), and 0.7 to 7.0 AL
DNA, in a final volume of 50 AL. The PCR conditions for
the detection of HPV were as follows: initial denaturation at
958C for 5 minutes; followed by 40 cycles of amplification
at 958C for 1 minute, 458C for 2 minutes, and 728C for
1.5 minutes; and a final extension step at 728C forSex
Male 49 13 72.2 36 63.2 .747
Female 26 05 27.8 21 36.8
Total 75 18 100 57 100
Tumor site
Tongue 20 02 11.1 18 31.6 .163
Mouth floor 18 04 22.2 14 24.6
Othersy 37 12 66.7 25 43.9
Total 75 18 100 57 100
4 v2 test.
y Lip, jugal mucosa, palate, retromolar trigone, and alveolar border.
Table 2
Comparison of age between HPV-positive and HPV-negative cases (Natal/
RN, 2005)
Age
HPV n Median Standard
deviation
Confidence
interval (95%)
P4
Negative 57 64.91 15.39 60.83-69.00 .859
Positive 18 65.67 16.53 57.45-73.89
4 Student t test.
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blot hybridization [6] using radioactive probes specific for
the 19 HPV types most common in mucosal (genital and
oral) infections.
The results were analyzed statistically by the Student
t test, Mann-Whitney test, and v2 test. The level of
significance was set at 95% (a = .05) for all tests. The
research project was approved by the Ethics Committee of
the Federal University of Rio Grande do Norte (no. 68/03).3. Results
Of the 75 cases positive for the human h-globin gene
(Fig. 1), HPV was detected in 18 (24%) (Fig. 2), including
13 (72.2%) men and 5 (27.8%) women. The v2 test showed
no significant association between the presence of HPV and
sex (Table 1). With respect to anatomical location, the most
frequent site affected was the tongue, followed by the floor
of the mouth, lip, jugal mucosa, palate, retromolar trigone,
alveolar border, and unidentified anatomical sites, with the
v2d test showing no significant association between HPV
and anatomical location of the tumor (Table 1). The mean
age of HPV-positive patients was 64.91 years, whereas the
mean age was 65.67 years in negative cases, with this
difference not being significant by the Student t test
(Table 2). The viral types found in the 18 positive cases
were the high-risk strains HPV-16 and/or HPV-18. HPV-18
was identified in 14 (77.8%) cases, double infection with
HPV-16 and HPV-18 was observed in 3 (16.7%) cases, and
HPV-16 was identified in only 1 case.4. Discussion
The present study investigated the presence of HPV
DNA in paraffin-embedded OSCC specimens by PCR
because this technique is the most sensitive for this purpose.
The sensitivity and specificity of PCR-based methods may
vary, mainly depending on the primer types, size of the PCR
product, reaction conditions, performance of the DNA
polymerase used, and capacity of detecting multiple virus
types [7]. In the present study, we used the GP5+/GP6+
primer pair because, in addition to detecting a variety of
virus types, it amplifies a small fragment (150 bp). This fact
is important when evaluating archived paraffin-embedded
tissue, as done in the present study, which may show
marked DNA fragmentation in some cases.There is currently no consensus regarding the best
method to quantify HPV in biological specimens, but one
of the most accurate and controlled assays available is real-
time PCR. However, this technique requires expensive
equipment and reagents [8]. Ha et al [8], using a quantitative
PCR method, detected HPV DNA in only 1 (2.9%) of the
34 specimens analyzed. However, it should be emphasized
that these authors used only primers specific for HPV-16, a
fact that might have underestimated the number of positive
cases if other virus types were present in the sample.
Human papillomavirus DNAwas detected in 18 (24%) of
the 75 cases evaluated. In the present investigation, only
high-risk HPV-16 and/or HPV-18 was identified, in agree-
ment with other studies [7]. In most cases (14/18, 77.8%),
only HPV-18 alone was detected; in 3 cases (16.7%), both
HPV-18 and HPV-16 were identified; and in 1 case, only
HPV-16 was detected. The present results agree with those
reported by Shima et al [9], Giovannelli et al [10], and Lo
Muzio et al [11], who detected HPV-18 in most of their
samples at frequencies of 54%, 87.5%, and 87%, respec-
tively. However, HPV-16 was the most frequent type in
other studies [11-13]. These divergent results suggest that
the higher prevalence of HPV-18 observed here might be
related to geographic and environmental factors or to race,
peculiar aspects of our sample.
Regarding clinical variables, in the present study, no
significant difference in HPV detection was observed
between sexes. Human papillomavirus DNA was detected
in 13 (26.5%) of the 49 male cases investigated, whereas
5 (19.2%) of the 26 female cases were positive for the virus,
in agreement with other investigators [3,10,14-16]. In
contrast, Zhang et al [13] observed a higher frequency of
HPV infection in men (81.3%) compared with that in
women (60%).
With respect to patient age, in the present study, no
significant difference was observed between HPV-positive
and HPV-negative patients (P = .859), in agreement with
the results of other investigators who observed no direct
relationship between these factors [3,4,15]. However,
Giovannelli et al [10] found that HPV-positive patients with
OSCC were older than patients not infected with the virus.
These results may suggest that HPV acts independently of
age; however, considering that HPV is a sexually transmit-
ted virus, younger patients with OSCC would have a higher
chance of being infected with the virus.
No association between the anatomical location of OSCC
and HPV was observed in the present study, a fact also
reported by Zhang et al [13]. However, D’Costa et al [14]
and Schwartz et al [17] found a higher frequency of
HPV in tongue OSCC, whereas Premoli-De-Percoco and
Ramirez [18] and Sugiyama et al [19] observed higher rates
in cases in which the tumor involved the floor of the mouth
and jugal mucosa.
Several authors had investigated the association between
HPV and the tumoral stages and the size of primary tumor,
as well as between this oncovirus and the excessive
R.C. Soares et al. / American Journal of Otolaryngology–Head and Neck Medicine and Surgery 28 (2007) 397–400400consumption of alcohol and/or tobacco, and had observed
that there was no significant association between the
presence of the HPV and these aspects [1,3,11,13,17,
20-24]. Based on these results, we decided not to include
these data in the study.5. Conclusions
In the present study, HPV DNA was detected in a low
percentage of OSCC cases (24%), suggesting that HPV
plays an important role in the development and progression
of OSCC in only a small subgroup of tumors. HPV-18 was
the most prevalent type, suggesting that this type was
specifically related to the development of OSCC in the
present samples. No significant association was observed
between the presence of HPV and age, sex, or anatomical
location of the tumor, thus indicating that these factors do
not interfere with the pathogenesis of HPV in OSCC.References
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